VPA has been associated with reduced HMGB1 levels in patients with post-stroke epilepsy [36], suggesting that its anti-inflammatory action may lead to secondary stabilization of the BBB by attenuating HMGB1-mediated permeability changes. Here, HMGB1 is linked to epilepsy.